| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |